Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD : A Historical Real-World Non-Inferiority Study

View/Open
Voorham_et_al_IJCOPD_ExtrafineBeclometasoneDipropionate_VoR.pdf (801.8Kb)
Publication date
29/10/2020
Author
Metadata
Show full item record
Citation
Voorham , J , Baldi , S , Santoro , L , Kerkhof , M , Contoli , M , Kerstjens , H AM , Lopez-Campos , J L , Roche , N , Singh , D , Vogelmeier , C F & Price , D B 2020 , ' Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD : A Historical Real-World Non-Inferiority Study ' , International journal of chronic obstructive pulmonary disease , vol. 2020 , no. 15 , pp. 2739—2750 . https://doi.org/10.2147/COPD.S269287
URI
https://hdl.handle.net/2164/15293
DOI
https://doi.org/10.2147/COPD.S269287
Rights
© 2020 Voorham et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
Collections